CONNECT WITH US
HealthTech

HealthTech

Blocking a nerve protein could interrupt chronic pain rather than simply mask it

Medical Xpress logo

Published on

Add as a preferred source on Google
Blocking a nerve protein could interrupt chronic pain rather than simply mask it

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

Chronic pain can continue long after an initial injury. When a nerve outside the brain and spinal cord (a peripheral nerve) is damaged and does not heal properly, it keeps sending constant pain signals. Over time, this nonstop bombardment of pain signals changes how your spinal cord and brain process information as sensory and emotion-associated circuits become hyperreactive, turning up the volume on pain.

Current pain treatments do not work well for everyone and can cause significant side effects. Painkillers like morphine just hide the pain, but researchers at Boston University Chobanian & Avedisian School of Medicine have identified the underlying problem.

They found that when they blocked a protein called RGS4 in the dorsal root ganglia innervating the lumbar spinal cord in an experimental model, the nervous system returned to a calm, normal state. The findings appear in the journal Science Signaling.

"Our findings suggest that one reason pain may become chronic is that sensory nerves themselves undergo molecular changes that keep them unusually sensitive," explains corresponding author Venetia Zachariou, Ph.D., Edward Avedisian Professor and chair of the department of pharmacology, physiology and biophysics at the school.

"By reducing RGS4 activity, our models were allowed to recover from abnormal pain sensitivity, while increasing RGS4 could make otherwise uninjured models more sensitive to pain.



Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.